Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Denmark: COPSAC, Copenhagen Prospective Study of Childhood Asthma, researchers in Copenhagen, Denmark, noted that a higher risk...
Read Full News1.
Biomarker panel offers hope for early pancreatic cancer detection
2.
A new way to measure suicide risk?
3.
FDA Approves CAR-T Product Use for Myeloma Early.
4.
The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.
5.
AACR: American Association for Cancer Research
1.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
2.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
3.
How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?
4.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
5.
Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge